Clinical trial Recruiting at 1 site Interventional Ages 19 to 35 Women only

Breathing retraining for pregnant women with POTS

Official title: Effects of Breathing Retraining Exercises on Heartrate, Blood Pressure and Orthostatic Intolerance in Pregnant Females With Postural Orthostatic Tachycardia Syndrome.

Run by Riphah International University · NCT07579026 · Data updated 2026-11-12

This trial will test whether diaphragmatic breathing exercises help pregnant women with POTS reduce dizziness, rapid heart rate, and other orthostatic symptoms.

More Blood Pressure trials

Quick facts

Study typeInterventional
Ages19 Years to 35 Years
SexWomen only
Enrollment44 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Sialkot, Punjab Province)
StatusRecruiting
StartedAugust 31, 2025
Main results expectedSeptember 2026
Study endsSeptember 2026
Registry record updatedMay 11, 2026
Trial IDNCT07579026 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant females aged 19–35 with POTS defined by a sustained heart rate increase of ≥30 bpm on standing (or ≥120 bpm) and orthostatic symptoms are eligible.

Probably not a fit

Women with uncontrolled hypertension or pre-eclampsia, significant cardiovascular disease, uncontrolled diabetes, severe anemia, advanced heart failure, neurodegenerative disease, or a history of deep venous thrombosis are excluded and unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional trial will enroll 44 pregnant women with postural orthostatic tachycardia syndrome at two hospitals in Sialkot, Pakistan, over about 10 months. Participants will be randomized to diaphragmatic breathing exercises (experimental) or educational retraining (control), with both groups also receiving baseline progressive muscle relaxation. Outcome measures include orthostatic symptom burden (Vanderbilt Orthostatic Symptom Score), heart rate and blood pressure responses to standing, and symptom reports. The protocol uses non-probability convenience sampling and regular site follow-ups for intervention delivery and data collection.

Why it matters

Potential benefit: If successful, this could provide a low-cost, non-drug way to reduce orthostatic symptoms and improve daily comfort for pregnant women with POTS.

How similar studies have gone: Breathing retraining and paced breathing have shown autonomic and symptom benefits in other populations, but evidence specifically for pregnant patients with POTS is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* • Pregnant female between the age of 19 to 35 years.

  * Active standing results in a sustained increase in heart rate (HR) of at least 30 bpm or ≥120 bpm.
  * POTS patients with a subacute onset of lightheadedness, dizziness, and presyncope provoked by standing.
  * palpitations with chest discomfort, breathing difficulties, or feeling faint

Exclusion Criteria:

* • Uncontrolled hypertension/pre-eclampsia

  * cardiovascular disorder
  * Patients with uncontrolled diabetes
  * Patient with Anemia, severe heart failure and neurodegenerative diseases.
  * Females with the history of deep venous thrombosis.

Where it's running

  • Bashir hospital sialkot, fatima hospital
    Sialkot, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.